Implantation Rate of Vitrified-warmed Collapsed Blastocysts

June 8, 2015 updated by: Lisbet Van Landuyt, Centre for Reproductive Medicine, Belgium

Randomized Controlled Trial Comparing the Implantation Rate of Vitrified-warmed Blastocysts With and Without Artificial Shrinkage Before Vitrification

In our centre, the implantation rate of frozen blastocysts (cryopreserved using vitrification)was 20,3% (Van Landuyt et al. 2011). This implantation rate is lower when compared to data from other observational studies. Retrospective studies have shown that artificial shrinkage of the blastocoelic cavity (also called collapse) and dehydration of the blastocyst just before vitrification can have a positive effect on the survival after warming. This collapse can be induced by using a laser. The study of Iwayama et al. 2010 has shown a similar survival rate but an increase in the implantation rate of collapsed blastocysts compared to non-collapsed blastocysts.

The aim of the study is to investigate the effect of artificial shrinkage by laser-induced collapse on the implantation potential of vitrified-warmed day 5 or day 6 blastocyst stage embryos in a prospective randomised controlled trial.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

270

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1090
        • Centre for Reproductive Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 34 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • female age <39 years
  • at least 1 blastocyst available for cryopreservation

Exclusion Criteria:

  • sperm origin: testicular or epididymal sperm extraction
  • IVM (in-vitro maturation) cycles
  • PGD cycles (preimplantation genetic diagnosis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Collapse
This arm includes the patients where laser-induced collapse (=artificial shrinkage) of all blastocysts is performed before vitrification
inducing collapse (= artificial shrinkage) by applying 1 or 2 laser pulses between trophectoderm cells of the blastocyst to be vitrified
Other Names:
  • artificial shrinkage
No Intervention: control
This control arm includes the patients of which the blastocysts are vitrified without performing collapse

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
implantation rate of the embryo in the first frozen transfer cycle
Time Frame: approximately 10 weeks after the first frozen embryo transfer
patients are enrolled in the study at oocyte retrieval. When patient is not pregnant after fresh embryo transfer, she comes back to use the frozen embryos at least one month after the initial inclusion. After the frozen embryo transfer, poshCG is measured 14 days after transfer. Approximately 10 weeks after transfer, implantation rate of the frozen embryos is assessed. This is the number of intra-uterine gestational sacs seen on ultrasound on the number of embryos transferred
approximately 10 weeks after the first frozen embryo transfer

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
survival rate of warmed blastocysts
Time Frame: 0-30 minutes
this is the morphological assessment of survival of the blastocyst after warming
0-30 minutes
implantation rate per warmed blastocyst
Time Frame: approximately 10 weeks after first frozen transfer
implantation rate of the transferred embryo per embryo initially warmed in that frozen transfer cycle.
approximately 10 weeks after first frozen transfer

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisbet Van Landuyt, MSc, Centre for Reproductive Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

October 28, 2013

First Submitted That Met QC Criteria

November 4, 2013

First Posted (Estimate)

November 8, 2013

Study Record Updates

Last Update Posted (Estimate)

June 9, 2015

Last Update Submitted That Met QC Criteria

June 8, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • VanLanduyt2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implantation Rate of Vitrified Blastocysts

Clinical Trials on Collapse

Subscribe